Add like
Add dislike
Add to saved papers

Prevalence of reactivity to the tuberculin test and associated factors in the population attended at a drug addiction center in the period 2013-2016.

Objective: Epidemiological study of prevalence, carried out at Center for Drug Addiction of the center of addictions of Nou Barris (Barcelona, Spain) during 2013-2016 in order to know the prevalence of tuberculin test reactivity (TTR) and its predictive factors in drug-dependent population.

Material and methods: Epidemiological and clinical variables, associated with the consumption of drugs and the practice of the tuberculin test, were collected. The reading rate and the prevalence of TTR for annual periods, as well as the predictive factors through a bivariate and multivariate logistic regression analysis.

Results: 389 patients were studied (109 in 2013, 84 in 2014, 111 in 2015 and 85 in 2016) and they went to the reading of the TT 337 (86.6%). The prevalence of TTR was 33.2% in the readings. At the bivariate level, TTR was associated with sex, origin and prior history. In the multivariate analysis, the predictive value of age was confirmed (more reactivity in ≥40 years; p <0.001, odds ratio [OR]: 4.85, confidence interval [IC]: 2.68-8.78), being male (p = 0.003, OR: 2.81, IC: 1.43-5.53), and being an immigrant (p <0.001; OR: 7.32, IC: 3.56-15.03).

Discussion: It is concluded that the prevalence of TTR is high, especially in men, in those of more age, and in immigrants and that the drug addiction devices continue to be basic in the detection and monitoring of the latent tuberculosis infection.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app